Hans Lilja
171 – 180 of 469
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
We need a better marker for prostate cancer. How about renaming PSA?
- Contribution to journal › Debate/Note/Editorial
- 2011
-
Mark
Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys(145) or Lys(146) from fPSA without internal cleavages at Lys(145) or Lys(146)
- Contribution to journal › Article
-
Mark
Three genes expressing Kunitz domains in the epididymis are related to genes of WFDC-type protease inhibitors and semen coagulum proteins in spite of lacking similarity between their protein products
- Contribution to journal › Article
-
Mark
Tumor markers in prostate cancer I: Blood-based markers
- Contribution to journal › Scientific review
-
Mark
A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
- Contribution to journal › Article
-
Mark
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
- Contribution to journal › Article
-
Mark
Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples
- Contribution to journal › Article
-
Mark
Percentage of Free Prostate-specific Antigen: Implications in Modern Extended Scheme Prostate Biopsy EDITORIAL COMMENT
- Contribution to journal › Debate/Note/Editorial
-
Mark
Prostate-specific Antigen/Solvent Interaction Analysis: A Preliminary Evaluation of a New Assay Concept for Detecting Prostate Cancer Using Urinary Samples EDITORIAL COMMENT
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.
- Contribution to journal › Article
